Tidal Investments LLC Raises Stock Holdings in Brainsway Ltd. Sponsored ADR $BWAY

Tidal Investments LLC raised its stake in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) by 492.8% during the second quarter, HoldingsChannel reports. The institutional investor owned 89,248 shares of the company’s stock after purchasing an additional 74,193 shares during the quarter. Tidal Investments LLC’s holdings in Brainsway were worth $1,384,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of BWAY. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Brainsway in the 1st quarter valued at approximately $40,000. Ballast Advisors LLC acquired a new stake in Brainsway in the 1st quarter valued at approximately $55,000. Nano Cap New Millennium Growth Fund L P purchased a new stake in Brainsway in the fourth quarter valued at approximately $209,000. Royal Bank of Canada raised its position in Brainsway by 84.2% in the first quarter. Royal Bank of Canada now owns 15,490 shares of the company’s stock valued at $206,000 after purchasing an additional 7,080 shares during the period. Finally, Bank of America Corp DE purchased a new stake in Brainsway in the first quarter valued at approximately $206,000. Hedge funds and other institutional investors own 30.11% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. LADENBURG THALM/SH SH raised their price target on Brainsway from $18.00 to $18.80 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Weiss Ratings downgraded Brainsway from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, August 19th. New Street Research reissued a “buy” rating on shares of Brainsway in a research note on Friday, July 24th. Wall Street Zen upgraded Brainsway from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $19.00 target price on shares of Brainsway in a research report on Tuesday, September 8th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $18.20.

Brainsway Trading Up 0.6%

Brainsway stock opened at $13.61 on Friday. The firm has a market capitalization of $547.26 million, a P/E ratio of 30.93 and a beta of 1.25. Brainsway Ltd. Sponsored ADR has a twelve month low of $7.14 and a twelve month high of $17.40. The stock’s fifty day simple moving average is $14.91 and its 200-day simple moving average is $14.81.

Brainsway (NASDAQ:BWAY) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.04. The business had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.54 million. Brainsway had a return on equity of 12.74% and a net margin of 15.65%. Sell-side analysts predict that Brainsway Ltd. Sponsored ADR will post 0.33 earnings per share for the current year.

About Brainsway

BrainsWay Ltd. is a medical technology company that develops and commercializes noninvasive therapies for brain disorders. Its principal technology, Deep Transcranial Magnetic Stimulation (Deep TMS), uses electromagnetic fields to stimulate targeted areas of the brain and is designed to reach deeper and broader regions than conventional transcranial magnetic stimulation.

The company’s product portfolio includes Deep TMS systems, treatment coils, and related software and accessories. Its systems are used by mental health professionals for conditions including major depressive disorder, obsessive-compulsive disorder, and smoking cessation, subject to applicable regulatory clearances and local requirements.